Allée de la Recherche 60
UCB is a global biopharmaceutical company, with a focus on neurology and immunology. Our business is strong. Total revenue grew to €4.2 billion in 2016. We are more than 7,700 people in all four corners of the globe, inspired by patients and driven by science.